Brain implant that thinks for itself could transform Parkinson's care

NCT ID NCT07635823

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new type of deep brain stimulation (DBS) that automatically adjusts its settings based on real-time brain signals, unlike standard DBS which uses fixed stimulation. Sixty people with Parkinson's disease will have a special neurostimulator implanted and then experience both the adaptive and conventional modes in a randomized, double-blind crossover design. The goal is to see if the adaptive system improves daily 'on' time without troublesome movement side effects, motor symptoms, and quality of life compared to the standard approach.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
adaptive deep brain stimulation (aDBS) device
What this could lead to
If successful, this could offer Parkinson's patients a more personalized treatment that automatically adjusts stimulation to their needs, potentially improving symptom control and quality of life.
What could go wrong
This is a relatively small, early-stage trial (60 people) comparing two device modes, not a new drug. The benefits may be modest, and not everyone may respond well to the adaptive mode.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (PD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Tiantan Hospital, Capital Medical University

    RECRUITING

    Beijing, Beijing Municipality, 10000, China

  • First Affiliated Hospital, Sun Yat-Sen University

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, China

  • Nanjing Brain Hospital

    RECRUITING

    Nanjing, Jiangsu, China

  • Peking Union Medical College Hospital

    NOT_YET_RECRUITING

    Beijing, Beijing Municipality, China

  • Qilu Hospital of Shandong University

    NOT_YET_RECRUITING

    Jinan, Shandong, China

  • The First Affiliated Hospital of USTC (Anhui Provincial Hospital)

    NOT_YET_RECRUITING

    Hefei, Anhui, China

  • West China Hospital

    NOT_YET_RECRUITING

    Chengdu, Sichuan, China

  • Xiangya Hospital of Central South University

    RECRUITING

    Changsha, Hunan, China

  • Xuanwu Hospital, Capital Medical University

    RECRUITING

    Beijing, Beijing Municipality, 10000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.